An act to amend Section 11833.05 of, and to add Chapter 7.45 (commencing with Section 11833.06) to Part 2 of Division 10.5 add Title 1.6G (commencing with Section 1789.40) to Part 4 of Division 3 of, the Health and Safety Civil Code, relating to substance use disorder.
SB 43 would create a new licensing and compliance framework for addiction treatment referral agencies in California. The bill defines a “referral agency” as a private for-profit or nonprofit entity that refers people, for remuneration, to certified substance use disorder programs or licensed facilities. Before operating or making paid referrals, such an agency would have to obtain a certificate of compliance from the Department of Justice, pay a fee tied to regulatory costs, and submit detailed application information about ownership, management, fees, and prior disciplinary or criminal history. The bill also requires the certificate to be posted publicly and updated when ownership, location, or key management changes occur.
The bill would also regulate how referral agencies may participate in group advertising and referral services. It would prohibit certain financial relationships between referral agencies and the treatment programs or facilities they refer to, require disclosure if most referrals go to a limited number of member programs, and require agencies to file standard form contracts with the department while keeping those contracts confidential. In addition, certified programs and licensed facilities would have to report annual money transfers with recovery residences, adding a new disclosure requirement aimed at financial transparency in the treatment ecosystem.
SB 43 would significantly expand enforcement tools. The Department of Justice could suspend or revoke a certificate of compliance and assess civil penalties of up to $20,000 for violations. The Attorney General could bring civil actions against unlicensed referral activity and recover penalties equal to the remuneration illegally received. District attorneys, county counsels, city attorneys, and injured persons could also sue for declaratory relief and civil penalties. The bill creates a misdemeanor for operating a group advertising and referral service without providing required identifying information, which makes it a state-mandated local program. It also exempts local public agencies that provide free referral services when otherwise authorized by law.
The general sentiment reflected in the bill’s progression appears supportive of stronger oversight and consumer protection in addiction treatment referrals. The bill advanced through committee with unanimous votes in the available history and was placed on the suspense file, suggesting it was viewed as policy-worthy but with fiscal or implementation considerations. The absence of recorded opposition in the provided materials points to broad procedural support, though the suspense-file action indicates lawmakers were still weighing cost and administrative burden.
The main point of contention is likely the balance between transparency and business confidentiality. The bill requires referral agencies to file standard form contracts with the department but expressly keeps those contracts confidential, and the Legislature states this is needed to preserve competition and encourage participation. Other possible concerns include the new licensing burden on referral agencies, the prohibition on financial interests between agencies and treatment providers, and the creation of new criminal and civil penalties. Supporters would likely view these provisions as anti-kickback and anti-fraud safeguards, while critics may see them as restrictive or costly to comply with.
SB 43 would add a new title to the Civil Code governing addiction treatment referral agencies and would amend Health and Safety Code disclosure requirements for certified programs and licensed facilities. It would place paid referral agencies under a certificate-of-compliance system administered by the Department of Justice, impose reporting and posting requirements, restrict financial ties between referral agencies and treatment providers, and authorize civil, administrative, and criminal enforcement. It would also require annual reporting of money transfers between treatment providers and recovery residences, expanding state oversight of financial relationships in the substance use disorder treatment market.
The available voting history suggests the bill was generally received positively in committee, with unanimous votes shown in the provided actions and no recorded committee opposition. At the same time, the bill was sent to and placed on the Appropriations suspense file, indicating that fiscal impact and administrative implementation were important considerations. Overall, the tone appears supportive of regulation and consumer protection, with lawmakers still attentive to cost and operational effects.
The most notable tension in SB 43 is between transparency and confidentiality. The bill requires referral agencies to submit standard form contracts to the department, but it also exempts those contracts from public inspection, and the Legislature explicitly justifies that exemption as necessary to preserve competition and participation. Another likely area of concern is the scope of regulation: the bill imposes a new licensing regime, fee requirements, ownership disclosures, conflict-of-interest restrictions, and penalties, which could be viewed by referral agencies as burdensome. Supporters would likely argue these measures are needed to curb kickbacks, steering, and misleading referral practices in addiction treatment.